DrugPatentWatch Database Preview
CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which patents cover Calcipotriene And Betamethasone Dipropionate, and when can generic versions of Calcipotriene And Betamethasone Dipropionate launch?
Calcipotriene And Betamethasone Dipropionate is a drug marketed by Perrigo Uk Finco and Tolmar and is included in two NDAs.
The generic ingredient in CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE is betamethasone dipropionate; calcipotriene. There are sixty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
Summary for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 13 |
| Patent Applications: | 2 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE at DailyMed |
Recent Clinical Trials for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Celgene Corporation | Phase 4 |
| Psoriasis Treatment Center of Central New Jersey | Phase 4 |
| Icahn School of Medicine at Mount Sinai | Phase 4 |
See all CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE clinical trials
Pharmacology for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
| Drug Class | Vitamin D Analog Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Synonyms for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
| 485805-18-3 |
| Betamethasone dipropionate and calcipotriene |
| Betamethasone dipropionate mixture with calcipotriene |
| Betamethasone dipropionate-calcipotriene mixt. |
| Calcipotriol/betamethasone dipropionate |
| Daivobet |
| Dovobet |
| Enstilar |
| LEO 80185 |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)-, (11beta,16beta)-, mixt. with (1alpha,3beta,5Z,7E,22E,24S)-24-cyclopropyl-9,10-secochola- 5,7,10(19),22-tetraene-1,3,24-triol |
| SCHEMBL18863209 |
| Taclonex scalp |
| Xamiol |
US Patents and Regulatory Information for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Perrigo Uk Finco | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | betamethasone dipropionate; calcipotriene | OINTMENT;TOPICAL | 200174-001 | Dec 12, 2014 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Tolmar | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | betamethasone dipropionate; calcipotriene | OINTMENT;TOPICAL | 201615-001 | Jan 14, 2013 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
